Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Core One Labs Inc. (C:COOL)

Business Focus: Alternative Medicine

Oct 16, 2021 09:00 pm ET
Core One Labs Applauds the City of Seattle in Their Efforts to Decriminalize Psylocibin and Other Natural Occuring Entheogenic Drugs
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (FWB: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted...
Aug 15, 2021 01:56 pm ET
Core One Labs Applauds TheraPsil on Its Submission to Health Canada
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic...
Aug 13, 2021 02:55 am ET
Core One Labs’ Clinics Submit Application to Treat Patient With Psilocybin Psychedelic-Assisted Therapy
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic...
Aug 07, 2021 07:55 pm ET
Core One Labs to Move Its Psychedelic Formulations for the Treatment of Stroke and Depression Toward Clinical Development
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that the scientific team of its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has initiated the next step in...
Aug 05, 2021 01:15 am ET
Core One Labs’ Virtual Town Hall Reveals Company is Nearing Production of Biosynthesized Psilocybin: Breakthrough In the Psychedelic Space Expected Upon Successful Completion
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is a research and development company focused on bringing psychedelic medicines to market through the development and production of API grade...
Jul 30, 2021 03:10 am ET
Core One’s Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc....
Jul 26, 2021 07:00 am ET
Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of another breakthrough psychedelic drug...
Jul 21, 2021 03:00 am ET
Core One Labs’ Akome Biotech Protects New AKO003 Ketamine-Based Breakthrough Drug Formulation For Depression Treatment
Core One Labs Inc. (CSE: COOL) (OTC: CLABD) (Frankfurt: LD6, WKN:A3CSSU) (the “Company”) is excited to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has protected its breakthrough ketamine psychedelic drug formulation for...
Jul 17, 2021 07:00 pm ET
Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that Dr. Robert E.W. Hancock, the Company’s Chairman, and CEO of its wholly owned subsidiary Vocan Biotechnologies Inc....
Jul 16, 2021 03:00 am ET
Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements
Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that it is pursuing a listing on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) to enhance the...
Jul 14, 2021 02:33 pm ET
CSE Bulletin: Consolidation - Core One Labs Inc. (COOL)
Toronto, Ontario--(Newsfile Corp. - le 14 juillet/July 2021) Core One Labs Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common share for every eight (8) pre-consolidation common shares.
Jun 21, 2021 09:15 am ET
REPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of a next-generation psychedelic drug...
Jun 19, 2021 06:30 pm ET
New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of a next-generation psychedelic drug...
Jun 18, 2021 03:00 am ET
Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce it has retained Smart & Biggar LLP (“Smart and Biggar”) to handle all IP filings for Akome Biotech Ltd. (“Akome”) and Vocan...
Jun 16, 2021 03:00 am ET
Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) advises that in preparation of a potential listing of its common shares on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”...
Jun 14, 2021 09:15 am ET
REPEAT - Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (“Vocan”), a company operating under one of few Health Canada Controlled...
Jun 12, 2021 06:39 pm ET
Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (“Vocan”), a company operating under one of few Health Canada Controlled...
May 21, 2021 09:28 am ET
Core One Labs Provides Clarification on Trading Activity
VANCOUVER, BC / ACCESSWIRE / May 21, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the "Company" or "Core One"). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada ("IIROC") and the Canadian Securities Exchange ("CSE"). Statements made in the news release issued by the Company on May 4, 2021 indicated that the Company had been made aware of potentially manipulative trading activity in its common shares. The news release issue
May 06, 2021 09:00 am ET
REPEAT – Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation...
May 06, 2021 03:10 am ET
Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) has commenced the development of its next-generation...
May 05, 2021 09:00 am ET
REPEAT - World Renowned Physician Joins Core One Labs as Chief Medical Officer
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“Akome”), as Chief Medical Officer...
May 05, 2021 03:10 am ET
World Renowned Physician Joins Core One Labs as Chief Medical Officer
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“Akome”), as Chief Medical Officer...
May 04, 2021 04:01 pm ET
Core One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") wishes to confirm that management is unaware of any material change in the Company's operations that would account for the recent and significant share price depreciation in the Company's stock.
May 04, 2021 09:00 am ET
REPEAT - Core One Labs Completes Milestone Acquisition of Akome Biotech
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to...
May 04, 2021 03:10 am ET
Core One Labs Completes Milestone Acquisition of Akome Biotech
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to...
Apr 29, 2021 08:45 pm ET
Core One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board
VANCOUVER, BC / ACCESSWIRE / April 29, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce it has appointed Dr. Dan Polonenko to its Advisory Board, effective immediately. Dr. Polonenko has also agreed to consult the Company and will assist in the filing of any patents the Company intends to file.
Apr 29, 2021 09:00 am ET
REPEAT -- Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has...
Apr 29, 2021 04:00 am ET
Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”), a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce that it has...
Apr 28, 2021 09:00 am ET
REPEAT -- Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has entered into a letter of intent, dated April 27, 2021, with Lobe Sciences Ltd. (“Lobe”) pursuant to which the...
Apr 28, 2021 03:30 am ET
Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) is pleased to announce it has entered into a letter of intent, dated April 27, 2021, with Lobe Sciences Ltd. (“Lobe”) pursuant to which the...
Apr 26, 2021 09:00 am ET
Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia...
Apr 26, 2021 07:07 am ET
Emerging Markets Report: The Rich Get Richer
Blockbuster news out of Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) this past weekend. As you’ll recall Core One is a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines...
Apr 24, 2021 06:00 pm ET
Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia...
Apr 21, 2021 09:00 am ET
REPEAT: Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”) a life sciences research and technology company focused on bringing psychedelic medicines to market through novel delivery systems and...
Apr 21, 2021 04:05 am ET
Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”) a life sciences research and technology company focused on bringing psychedelic medicines to market through novel delivery systems and...
Apr 17, 2021 07:00 pm ET
Core One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce it has signed letter of intent (the "LOI") to acquire all of the outstanding share capital (the "Proposed Transaction") of Akome Biotech Ltd. ("Akome")..
Apr 14, 2021 11:00 pm ET
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company" or "Core One") announces that it has reached an agreement with Plant-Based Investment Corp. (formerly, Cannabis Growth Opportunity Corporation) (PBIC) ("PBIC") to rescind the share exchange transaction previously completed between the parties (the "Share Exchange").
Apr 14, 2021 11:16 am ET
Emerging Markets Report: A Moment for the Mushroom
Regular readers of the Emerging Markets Report are clear as to our affinity for mushrooms and psychedelic based companies. We are firm believers in the treatment possibilities for psylocibin, especially in mental health applications. And we...
Apr 06, 2021 06:00 am ET
Core One Labs Vocan Expands Product Commercialization Team
VANCOUVER, BC / ACCESSWIRE / April 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. ("Vocan") has expanded its product commercialization team, adding Dr. Elizabeth Matthews as Head of Scientific and Regulatory Affairs.
Mar 31, 2021 09:00 am ET
Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedel
VANCOUVER, BC / ACCESSWIRE / March 31, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) WKN: A2P8K3) ("Core One" or the "Company"), a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, is pleased to announce it has completed the acquisition (the "Transaction") of Ketamine Infusions Centers of Texas Inc. ("KICT"), a U.S.-based health and wellness clinic that provides keta
Mar 28, 2021 02:45 pm ET
Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
VANCOUVER, BC / ACCESSWIRE / March 28, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce that its wholly owned subsidiary Rejuva Mental Health Clinic (the "Clinic") has retained Dr. Stephen Peach as Lead Physician. Dr. Peach will be responsible for developing comprehensive patient intake and assessment protocols, with the goal of identifying individuals with a history of mental health disorders and addictions, that may benefit from alternative psychedelic medicines and the Clinic&
Mar 22, 2021 09:00 am ET
Repeat: Core One Labs Files Application to List its Common Shares on NASDAQ
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market LLC...
Mar 20, 2021 04:00 pm ET
Core One Labs Files Application to List its Common Shares on NASDAQ
Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed an application to list its common shares on the Capital Market tier of The NASDAQ Stock Market LLC...
Mar 14, 2021 11:35 pm ET
Core One Labs to Commence Trading in the US on OTC Pink Market
VANCOUVER, BC / ACCESSWIRE / March 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN: A2P8K3) (the "Company") a research and technology company focused on life sciences and bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy, is pleased to announce that the Financial Industry Regulatory Authority has accepted the Company's Form 211 for filing and that its common shares will commence trading in the United States on the OTC Pink Market under the ticker symbol "CLABF&q
Mar 12, 2021 03:00 am ET
Psychedelic Expert Core One Labs Reports Milestone Acquisition
The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients
Mar 09, 2021 03:05 am ET
Core One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
VANCOUVER, BC / ACCESSWIRE / March 9, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FSE:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce that in collaboration with Ketamine Infusions Centers of Texas LLC (KICT) it is exploring a development program for N-dimethyltryptamine (DMT) assisted psychotherapy to address anxiety and depression.
Mar 04, 2021 04:05 pm ET
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil
VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62, WKN: A2P8K3) (the "Company") is pleased to announce that its wholly owned subsidiary Vocan Biotechnologies Inc. has entered into a term sheet with Vocan Brazil Biotechnologies Inc. ("Vocan Brazil") for the licensing of its proprietary technology. Vocan Brazil is owned by Brazilian entrepreneur Mr. Marcelo Galvão, an arm's length party.
Feb 26, 2021 03:00 am ET
Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / Core One Labs Inc. (CSE:COOL), (OTC PINK:CLABF), (Frankfurt:LD62, WKN: A2P8K3) (the "Company" or "Core One") a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce readiness to begin initial biosynthetic psilocybin production trials.
Feb 24, 2021 03:00 am ET
Core One Labs Finalizes Deal to Acquire Ketamine Infusions Centers of Texas, Entering the US Market for Psychedelic Treatments
VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company" or "Core One") a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a definitive agreement to acquire (the "Transaction") Ketamine Infusion Centers of Texas Inc. (KICT), a US based health and wellness Ketamine Clinic. Th
Feb 10, 2021 11:05 pm ET
Core One Labs Highlights Key Points from International Investor Call
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) ("Core One" the "Company") is pleased with the tremendous turnout on the International Investors' Call held earlier today. Core One's Chairman, Dr. Robert E.W. Hancock and Chief Executive Officer, Joel Shacker provided participants an update on the Company's current Intellectual Property and patent application process, cost to produce psilocybin, and the commercial viability.
Feb 10, 2021 04:05 pm ET
Core One Labs Prepares First in Series of Patent Applications
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC Pink:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the "Company" or "Core One Labs") a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce preparations for filing a patent application encompassing its proprietary biosynthetic psilocybin production system.
Feb 09, 2021 04:05 pm ET
Core One Labs Announces Adding Video Conference Capabilities to Teleconference Call Scheduled for February 10, 2021 1:30 p.m. PST/4:30 p.m. EST
VANCOUVER, BC / ACCESSWIRE / February 9, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt::LD62) (WKN: A2P8K3) (the "Company") is pleased to announce that it has added video conference capabilities to its previously announced teleconference call scheduled for Wednesday, February 10, 2021 at 1:30 p.m. PST, 4:30 p.m. EST and 10:30 p.m. CET, with Dr. Robert E.W. Hancock, Chairman and Joel Shacker, CEO to discuss development and strategy.
Feb 06, 2021 05:30 pm ET
Core One Labs Engages Donohoe Advisory for Nasdaq Listing and Schedules Special Investor Call with Dr. Robert E.W. Hancock to Demonstrate Recent Research Outcome
VANCOUVER, BC / ACCESSWIRE / February 6, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") announces that it has engaged Donohoe Advisory Associates LLC ("Donohoe Advisory") in connection with its efforts to seek a listing for its common shares on a NASDAQ Stock Market. The Company expects that listing its common shares on NASDAQ will provide increased investor awareness and market liquidity for shareholders.
Feb 04, 2021 03:25 am ET
Core One Labs Announces Its Entrance into the Ketamine Space with Proposed Acquisition of Ketamine Infusion Centers of Texas
VANCOUVER, BC / ACCESSWIRE / February 4, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") a biotechnology research and development company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a letter of intent (the "Letter of Intent") dated January 20, 2021 with Ketamine Infusion Centers of Texas, LLC ("KICT"), an arms-length-party, to review a pote
Jan 23, 2021 01:25 pm ET
Core One Labs Announces Vocan Assembles Equipment to Produce Biosynthesized Psilocybin
VANCOUVER, BC / ACCESSWIRE / January 23, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce its wholly-owned subsidiary Vocan Biotechnologies Inc. ("Vocan") has assembled the necessary equipment, which will allow the laboratory to commence the process of recombinant production of psilocybin. The process that engineers bacteria incorporating optimized biosynthetic genes from the Psilocybe cubensis mushroom, will enable the bacteria to act as a biological factory and synthe
Jan 15, 2021 05:05 pm ET
Core One Labs Completes Sale of Non-Core Assets
VANCOUVER, BC / ACCESSWIRE / January 15, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce that further to its October 30, 2020 press release, the Company has completed the sale of certain of its non-core assets and subsidiaries in California for CAD$3,000,000 plus the assumption of approximately USD$4,000,000 in related liabilities.
Jan 12, 2021 04:10 am ET
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
VANCOUVER, BC / ACCESSWIRE / January 12, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce its plans to initiate another intellectual property strategy that will utilize its patented transmucosal thinstrip delivery method ("thinstrip delivery method") in combination with its proprietary biosynthetic psilocybin, developed by its wholly-owned subsidiary, Vocan Biotechnologies Inc. ("Vocan").
Jan 07, 2021 03:10 am ET
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs
VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021.
Dec 31, 2020 04:55 pm ET
Core One Labs Completes Acquisition of Vocan Biotechnologies Inc.
VANCOUVER, BC / ACCESSWIRE / December 31, 2020 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company") is pleased to announce that, further to its press release of December 24, 2020, it has completed the acquisition (the "Transaction") of all of the outstanding share capital of Vocan Biotechnologies Inc. ("Vocan") effective December 31, 2020.
Dec 24, 2020 02:00 pm ET
Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) (the "Company") is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement (the "Purchase Agreement"), dated December 23, 2020, for the acquisition (the "Acquisition") of all of the outstanding share capital of Vocan Biotechnologies Inc. ("Vocan"), a Canadian-based genetic engineering and biosynthesis rese
Dec 02, 2020 07:48 pm ET
CSE Bulletin: Fundamental Change - Core One Labs Inc. (COOL)
Toronto, Ontario--(Newsfile Corp. - Le 2 decembre/December 2020) - Core One Labs Inc. (CSE: COOL) has requalified for listing following a fundamental change review.
Dec 02, 2020 05:30 pm ET
Core One Labs Announces Resumption of Trading
VANCOUVER, BC / ACCESSWIRE / December 2, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABF)(FSE:LD62)(WKN:A14XHT) (the "Company") is pleased to announce that it has received approval from the Canadian Securities Exchange (the "CSE") to resume trading at the market open on Thursday, December 3, 2020 under the existing ticker symbol "COOL". The Company has undergone a re-qualification for listing on the CSE following its acquisition of interests in Rejuva Alternative Medicine Research Centre Inc. and Shahcor Health Services Inc.
Dec 02, 2020 03:37 pm ET
IIROC Trade Resumption - COOL
VANCOUVER, BC, Dec. 2, 2020 /CNW/ - Trading resumes in:
Oct 30, 2020 08:00 pm ET
Core One Labs Signs Letter of Intent to Sell Certain Assets
VANCOUVER, BC / ACCESSWIRE / October 30, 2020 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF), (Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce it has entered into a Letter of Intent (the "LOI") with High Tower Capital Inc. ("High Tower") dated effective October 15, 2020 to sell certain assets and subsidiaries to High Tower for CAD$3,000,000 and the assumption of USD$4,015,885 in related liabilities. High Tower will also assume all ongoing obligations related to the Assets (as defined below).
Oct 07, 2020 12:00 pm ET
Core One Labs Signs Letter of Intent to Acquire Vocan Biotechnologies
VANCOUVER, BC / ACCESSWIRE / October 7, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce it has entered into a Letter of Intent (the "LOI") dated effective October 1, 2020 to acquire all of the outstanding share capital of Vocan Biotechnologies Inc. ("Vocan").
Aug 27, 2020 12:00 pm ET
Core One Labs Announces Revocation of Cease Trade Order
VANCOUVER, BC / ACCESSWIRE / August 27, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62, WKN:A2P8K3) (the "Company") is pleased to announce that effective August 26, 2020 (the "Effective Date"), the British Columbia Securities Commission (the "BCSC") has issued an order revoking its cease trade order, originally issued in respect of the securities of the Company on July 15, 2020.
Aug 19, 2020 09:00 pm ET
Core One Labs Appoints New Chief Financial Officer
VANCOUVER, BC / ACCESSWIRE / August 19, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce that, effective immediately, Mr. Geoff Balderson has been appointed as Chief Financial Officer and Secretary of the Company. Mr. Balderson has an extensive background in business and has worked in the capital markets for over 20 years. He currently acts as an officer and director of multiple TSX Venture and Canadian Securities Exchange listed companies. Mr. Balderson is the President of Harmony Corporate Se
Jul 16, 2020 12:52 pm ET
CSE Bulletin: Suspensions
Toronto, Ontario--(Newsfile Corp. - July 16, 2020) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. A Cease Trade Orders have been issued by one or more securities commissions.
Jul 16, 2020 07:56 am ET
IIROC Trading Halt - COOL
VANCOUVER, BC, July 16, 2020 /CNW/ - The following issues have been halted by IIROC:
Jul 15, 2020 01:00 pm ET
Core One Labs Provides Update on Financial Statements and Management Cease Trade Order
VANCOUVER, BC / ACCESSWIRE / July 15, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62)(WKN:A2P8K3) (the "Company"). The Company wishes to advise its valued shareholders that the new management team ("Management") is currently working with its auditor and accountants around the clock to finalize its audited financial statements and the related management's discussion and analysis ("MD&A") for the year-ended December 31, 2019. With the majority of the Company's operations being located in Cali
Jul 14, 2020 11:02 am ET
IIROC Trading Halt - COOL
VANCOUVER, BC, July 14, 2020 /CNW/ - The following issues have been halted by IIROC:
Jul 10, 2020 05:00 pm ET
Core One Labs Completes Acquisition of Interest in Medical Clinics
TORONTO, ON / ACCESSWIRE / July 10, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62, WKN:A2P8K3) (the "Company") is pleased to announce that it has completed the acquisition (the "Acquisition") previously announced on June 5, 2020, of all of the outstanding share capital of Rejuva Alternative Medicine Research Centre Inc. ("Rejuva") and one-quarter of the non-voting participating share capital of Shahcor Health Services Inc. ("Shahcor").
Jul 07, 2020 04:00 pm ET
CSE Bulletin: Consolidation - Core One Labs Inc. (COOL)
Toronto, Ontario--(Newsfile Corp. -Le 7 juillet/July 2020) – Consolidation - Core One Labs Inc. (COOL)
Jul 07, 2020 09:00 am ET
Core One Labs Announces Effective Date of Share Consolidation
VANCOUVER, BC / ACCESSWIRE / July 7, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABF)(Frankfurt:LD6, WKN:A14XHT) (the "Company") is pleased to announce that its common shares will begin trading on a post-consolidated basis at the opening of markets on July 9, 2020 under the existing ticker symbol "COOL".
Jul 03, 2020 04:45 pm ET
Core One Labs Completes Private Placement Financing
VANCOUVER, BC / ACCESSWIRE / July 3, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABF)(Frankfurt:LD6, WKN:A14XHT) (the "Company") is pleased to announce that it has completed a non-brokered private placement of 42,105,264 units (each, a "Unit") at a price of $0.095 per Unit for gross proceeds of $4,000,000.08. Each Unit consists of one common share of the Company, and one-half-of-one common share purchase warrant (each, a "Warrant"). Each whole Warrant entitles the holder to acquire an additional common share of the Company at a
Jun 12, 2020 08:00 am ET
Core One Labs Granted Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) ("COOL" or the "Company") announced today that the British Columbia Securities Commission has granted the Company's request for a management cease trade order (the "MCTO"). As previously announced, the application for the MCTO was made by the Company in connection with the anticipated delay in the filing its financial statements for the year ended December 31, 2019 and the related management's discussion and analysis ("MD&A") and certifications (the "Annual Filings").
Jun 09, 2020 04:30 pm ET
Core One Labs Requests Management Cease Trade Order for Additional Time to Complete Annual Financial Statements and Related Filings
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) -  Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announced today that it anticipates additional delays in filing its financial statements for the year ended December 31, 2019 and the related management's discussion and analysis ("MD&A") and certifications (the "Annual Filings"). The Company is filing an application with the relevant securities authorities requesting that they issue a management cease trade order (an "MCTO").
Jun 05, 2020 08:00 am ET
Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) (the "Company") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent"), dated June 4, 2020, with Rejuva Alternative Medicine Research Centre Inc. ("Rejuva") and Shahcor Health Services Inc. ("Shahcor"), pursuant to which the Company proposes to acquire all of the outstanding share capital of Rejuva and one-quarter of the outstanding share capital of Shahcor (the "Transaction").
Jun 03, 2020 08:00 am ET
Core One Labs to Establish a Shareholder Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - June 3, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") is pleased to announce that it will establish a Shareholder Advisory Board (the "Advisory Board"). The advisory board will consist of three current shareholders who have had interest and involvement in the Company for several years. The team will use their public market knowledge to help improve investor relations between the Company and its shareholders.
Jun 02, 2020 11:04 am ET
Core One Labs Clarifies Information on Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD6), (WKN: A14XHT) ("COOL" or the "Company") provides this news release as correction to Mr. Shacker's bio, who was appointed to the Company's board of directors on May 29, 2020.
Jun 01, 2020 08:00 am ET
Core One Labs Inc. Announces Cancellation of Loan with Viva Capital Ventures, LLC and Grant of Incentive Stock Options
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2020) -  Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) ("COOL" or the "Company") announced that it has cancelled the loan transaction with Viva Capital Ventures, LLC ("Viva"). As previously announced, the Company's wholly owned subsidiary, LDS Development Corporation ("LDS Development") had entered into a secured loan agreement with Viva for the advance of up to USD$900,000 to be used to finance the construction of the dispensary building at LDS Development's property in Adelanto, CA. Notwithstanding the execution of the loan agreement, no funds had been advanced to the Company by Viva.
May 29, 2020 08:00 am ET
Core One Labs Inc. Announces Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD61) (WKN: A14XHT) ("COOL" or the "Company") is pleased to announce the appointment of Joel Shacker to the Company's Board of Directors.
Apr 29, 2020 07:51 pm ET
Core One Labs' Subsidiary Signs Loan for USD$900,000; Also Announces Extension of Filing Deadline for Annual and Interim Financial Statements and MD&A, Settlement of Debts for Shares and Resignation o
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announces that its wholly owned subsidiary, LDS Development Corporation, has entered into an agreement with Viva Capital Ventures LLC ("Viva") for a secured loan for USD$900,000 (the "Loan"). The Company also announces that it intends to rely on the blanket relief provided by the Canadian Securities Administrators in response to the COVID-19 pandemic. This relief provides issuers with a 45 day extension for filings required on or before June 1, 2020. Finally, the Company also announces that it has entered into agreements for the settlement of certain debts in exchange for shares of the Company, and that Yanika Silina, the Company's Chief Financial Officer, has resigned to pursue other opportunities.
Mar 18, 2020 04:30 pm ET
Core One Labs Signs Definitive Agreements for Previously Announced $1.5M Convertible Debt Facility with Cannabis Growth Opportunity Corporation
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD61) (WKN: A14XHT) ("COOL" or the "Company") is pleased to announced that, further to its news release dated February 11, 2020, the Company has signed definitive agreements with respect to a CDN$1,500,000 convertible debt facility with Cannabis Growth Opportunity Corporation ("CGOC").
Mar 17, 2020 05:56 pm ET
CGOC Announces Closing of Core One Labs Debenture Facility and Share-Swap
TORONTO, March 17, 2020 /CNW/ - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, is pleased to announce that the Company and Core One Labs Inc. (CSE: COOL) ("Core One") have closed their previously-announced convertible debenture facility and share-swap. Core One is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. Core One's technology produces infused strips that provide a new way to
Feb 19, 2020 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Completes 7th and 8th Harvests of Top Grade Flower at the Adelanto Indoor Grow
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed its seventh and eighth consecutive harvests at the Adelanto facility.
Feb 18, 2020 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., in Association with Reiziger Pty. Ltd. Begins to Show Strong Results
Vancouver, British Columbia--(Newsfile Corp. - February 18, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun a highly complex nutritional regimen to accelerate the growth of cannabis plants and increase flower yield and quality.
Feb 11, 2020 10:00 am ET
Core One Labs Signs Term Sheet for $1.5M Credit Facility with Cannabis Growth Opportunity Corporation
Vancouver, British Columbia--(Newsfile Corp. - February 11, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD6), (WKN: A14XHT) ("COOL" or the "Company") announces that it has signed a non-binding term sheet for a CDN$1,500,000 convertible loan facility (the "CGOC Loan Facility") to be advanced by Cannabis Growth Opportunity Corporation ("CGOC").
Feb 10, 2020 09:00 pm ET
CGOC Announces New Investments and Completes Share-Swap
TORONTO, Feb. 10, 2020 /CNW/ - Cannabis Growth Opportunity Corporation ("CGOC", or the "Company") (CSE: CGOC), a cannabis focused investment corporation with both public and private cannabis holdings, is pleased to announce new investments within its public portfolio in Grown Rogue International Inc. (CSE: GRIN) ("Grown Rogue"), Bhang Inc. (CSE: BHNG) ("Bhang") and Core One Labs Inc. (CSE: COOL) ("Core One"). Details of the Company's transactions with Grown Rogue, Bhang and Core One are outlined below.
Jan 28, 2020 08:00 am ET
Core One Labs Inc. Subsidiary, CSPA Group, Inc., Continues to Expand Extraction Capabilities with White Label and Wholesale Products
Vancouver, British Columbia--(Newsfile Corp. - January 28, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, CSPA Group, Inc. ("CSPA"), continues to expand its extraction capability using Color Remediation Technology ("CRT").
Jan 27, 2020 08:00 am ET
Core One Labs Proposes to Amend Outstanding Warrant Exercise Price Reduction
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announces proposed amendment to an earlier reduction in the exercise price of its outstanding share purchase warrants (the "Warrants"). On or about October 28, 2019, the Company proposed to reduce the Warrant Exercises price from CAD$3.00 per share (on a post-consolidation basis) to CAD$1.25 per share (the "Warrant Repricing") (see the news release the Company disseminated on October 30, 2019). The current proposal seeks to reduce the exercise price to CAD$0.40 per share (the "Updated Warrant Repricing"). Effectiveness of the Updated Warrant Repricing is subject to the unanimous approval of the registered holders of the Warrants.
Jan 23, 2020 08:00 am ET
Core One Labs' Rêveur Brand is Gaining Consumer Traction with its High Yield In-House Product
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") is pleased to see an increase in demand for Rêveur branded product being produced in its Adelanto facility.
Jan 21, 2020 08:00 am ET
Core One Labs Appoints Patrick Morris as Director
Vancouver, British Columbia--(Newsfile Corp. - January 21, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") is pleased to announce the appointment of Patrick Morris as an independent director of the Company.
Jan 03, 2020 02:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Completes Second and Third Harvests of Top Grade Flower at the Adelanto Indoor Grow
VANCOUVER, British Columbia, Jan. 3, 2020 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed its second and third on-going harvests at the Adelanto facility.
Dec 20, 2019 02:00 am ET
Core One Labs Inc.'s Subsidiary, Core Isogenics Inc., Completes its First Indoor Harvest
VANCOUVER, British Columbia, Dec. 20, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its subsidiary, Core Isogenics Inc., has harvested 345 pounds of flower from its indoor facility at 9501 Commerce Way in Adelanto. This is the first harvest from the facility and accounted for approximately 10% of the cultivation area.
Dec 17, 2019 02:01 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Begins Harvesting Indoor Grow
VANCOUVER, British Columbia, Dec. 17, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun its first harvest at the 9501 Commerce Way facility in Adelanto California.
Dec 09, 2019 02:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Teams up with Reiziger Pty. Ltd. to Showcase High Yielding Nutritional Cultivation Technology
VANCOUVER, British Columbia, Dec. 9, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has begun a highly complex nutritional regimen to accelerate the growth of cannabis plants and increase flower yield and quality.
Dec 05, 2019 02:00 am ET
Core One Labs Signs LOI for Cultivation Contract
VANCOUVER, British Columbia, Dec. 5, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that it has signed a letter of intent (the "LOI") to grow cannabis for a well-known California brand, Golden State Banana ("GSB"), with a set price for premium bud, bud, trim and processing.
Dec 04, 2019 02:03 pm ET
Core One Labs Announces Q3 2019 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, Dec. 4, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that the Company has filed its financial statements and MD&A for the three and nine month periods ended September 30, 2019, and provides an update on the corporate milestones achieved during the quarter.  The Company is happy to announce that its results continue to be very encouraging and show steady growth in inventory, and strong sales numbers for the year to date in Fiscal 2019.
Dec 03, 2019 02:00 am ET
Core One Labs Inc. has Filed a Trademark Application with WIPO Madrid for an Additional Trademark
VANCOUVER, British Columbia, Dec. 3, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that it has filed a Trademark Application with WIPO Madrid to trademark "CBDSTRIPS" in the United Kingdom, Germany and Spain. This is in addition to its CannaStrips™ filings.
Nov 27, 2019 02:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Flowering Room is Now Operational and Anticipating its First Harvest
VANCOUVER, British Columbia, Nov. 27, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, Core Isogenics Inc., has completed multiple transfers (approximately 6,400 seedlings) from the vegetation room to the flowering room.
Nov 25, 2019 02:00 am ET
Core One Labs Delivers New Rêveur Premium Indoor Flower Line
VANCOUVER, British Columbia, Nov. 25, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that it has shipped Rêveur premium indoor flower line to its distribution partner, Fenix Logistics.
Nov 21, 2019 07:00 am ET
Core One Labs' Subsidiary, Agrotech LLC, Completes 1,600 Pound Harvest of Sacramento Farm
VANCOUVER, British Columbia, Nov. 21, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its 50%-owned subsidiary, Agrotech LLC, has harvested 1,600 pounds from the Sacramento farm it manages and has completed drying and testing of the biomass.
Nov 18, 2019 07:00 am ET
Core One Labs Inc. Closes Agreement to Acquire Micro-Cultivation Facility in Canada
VANCOUVER, British Columbia, Nov. 18, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has completed the acquisition of Rainy Daze Cannabis Corp ("Rainy Daze") by purchasing all issued and outstanding shares of Rainy Daze in exchange for $100,000 cash and by issuing an aggregate of 3,500,000 unrestricted common shares of the Company to the current shareholders of Rainy Daze.
Nov 15, 2019 07:30 am ET
Core One Labs Inc. Announces Resignation of Yanika Silina as Director
VANCOUVER, British Columbia, Nov. 15, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that Yanika Silina has resigned from the Board of Directors. Ms Silina will remain as the CFO for the Company.
Nov 12, 2019 07:00 am ET
Core One Labs' Flagship Product CannaStrips™ Lands in Eight New Stores
VANCOUVER, British Columbia, Nov. 12, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its new non-exclusive distribution partner, Fenix Logistics, has delivered CannaStripsTM into eight new stores putting the total of stores CannaStripsTM have been delivered to at 50.
Nov 12, 2019 07:00 am ET
Core One Labs' Flagship Product CannaStrips™ Lands in Eight New Stores
VANCOUVER, British Columbia, Nov. 12, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its new non-exclusive distribution partner, Fenix Logistics, has delivered CannaStripsTM into eight new stores putting the total of stores CannaStripsTM have been delivered to at 50.
Nov 05, 2019 12:44 pm ET
Core One Labs Inc. Provides Clarification on Terms of Definitive Agreement to Acquire Micro-Cultivation Facility in Canada
VANCOUVER, British Columbia, Nov. 5, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to clarify the terms of its definitive agreement to acquire Rainy Daze Cannabis, which was announced on November 4, 2019. 
Nov 05, 2019 12:44 pm ET
Core One Labs Inc. Provides Clarification on Terms of Definitive Agreement to Acquire Micro-Cultivation Facility in Canada
VANCOUVER, British Columbia, Nov. 5, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to clarify the terms of its definitive agreement to acquire Rainy Daze Cannabis, which was announced on November 4, 2019. 
Nov 04, 2019 08:54 am ET
Core One Labs Inc., Signs a Definitive Agreement to Acquire Cultivation Facility in Canada
VANCOUVER, British Columbia, Nov. 4, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has signed a Definitive Agreement to acquire Rainy Daze Cannabis Corp., a British Columbia corporation. The corporation's assets include a long term lease for a facility currently under construction and scheduled to be completed in the 2nd Qtr of 2020. The facility comprises 2,210 square feet of canopy space and 3,500 square feet of operational purpose built building. Also included are 15 top proprietary genetics with the nece
Nov 04, 2019 08:54 am ET
Core One Labs Inc., Signs a Definitive Agreement to Acquire Cultivation Facility in Canada
VANCOUVER, British Columbia, Nov. 4, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has signed a Definitive Agreement to acquire Rainy Daze Cannabis Corp., a British Columbia corporation. The corporation's assets include a long term lease for a facility currently under construction and scheduled to be completed in the 2nd Qtr of 2020. The facility comprises 2,210 square feet of canopy space and 3,500 square feet of operational purpose built building. Also included are 15 top proprietary genetics with t
Oct 30, 2019 08:00 am ET
Core One Labs Proposes to Reduce Outstanding Warrant Exercise Price
VANCOUVER, British Columbia, Oct. 30, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its board of directors has approved a proposed reduction in the exercise price of its outstanding share purchase warrants (the "Warrants") from the current CAD$3.00 per share (on a post-consolidation basis) to CAD$1.25 per share (the "Warrant Repricing").  Effectiveness of the proposed Warrant Repricing is subject to the unanimous approval of the registered holders of the Warrants.
Oct 30, 2019 08:00 am ET
Core One Labs Proposes to Reduce Outstanding Warrant Exercise Price
VANCOUVER, British Columbia, Oct. 30, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its board of directors has approved a proposed reduction in the exercise price of its outstanding share purchase warrants (the "Warrants") from the current CAD$3.00 per share (on a post-consolidation basis) to CAD$1.25 per share (the "Warrant Repricing").  Effectiveness of the proposed Warrant Repricing is subject to the unanimous approval of the registered holders of the Warrants.
Oct 24, 2019 08:00 am ET
Highway 395 Dispensary Drive-Thru Moves Forward With City of Adelanto Adopting Ordinance Complying with California State Cannabis Regulations
VANCOUVER, British Columbia, Oct. 24, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that last night the City of Adelanto adopted ordinance 19-59 which will allow the City to mirror the State of California cannabis regulations for licensees in the City of Adelanto which will allow for the Highway 395 Dispensary Drive-Thru.
Oct 24, 2019 08:00 am ET
Highway 395 Dispensary Drive-Thru Moves Forward With City of Adelanto Adopting Ordinance Complying with California State Cannabis Regulations
VANCOUVER, British Columbia, Oct. 24, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that last night the City of Adelanto adopted ordinance 19-59 which will allow the City to mirror the State of California cannabis regulations for licensees in the City of Adelanto which will allow for the Highway 395 Dispensary Drive-Thru.
Oct 23, 2019 08:00 am ET
Core One Labs Inc. Signs a Letter of Intent to Acquire Cultivation Facility in Canada
VANCOUVER, Oct. 23, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has signed a non-binding letter of intent (the "LOI") to acquire all of the outstanding shares of 1210950 B.C. Ltd. dba Rainy Daze Cannabis Corp. ("Rainy Daze") in exchange for a cash payment of CAD$100,000 and 3,500,000 shares of the Company's common stock.
Oct 23, 2019 08:00 am ET
Core One Labs Inc. Signs a Letter of Intent to Acquire Cultivation Facility in Canada
VANCOUVER, Oct. 23, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has signed a non-binding letter of intent (the "LOI") to acquire all of the outstanding shares of 1210950 B.C. Ltd. dba Rainy Daze Cannabis Corp. ("Rainy Daze") in exchange for a cash payment of CAD$100,000 and 3,500,000 shares of the Company's common stock.
Oct 10, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Transfers Core Isogenics' Seedlings from Its Nursery Facility to Its Cultivation Facility
VANCOUVER, British Columbia, Oct. 10, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has transferred Core Isogenic seedlings from its nursery facility to its cultivation facility.
Oct 10, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Transfers Core Isogenics' Seedlings from Its Nursery Facility to Its Cultivation Facility
VANCOUVER, British Columbia, Oct. 10, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has transferred Core Isogenic seedlings from its nursery facility to its cultivation facility.
Oct 03, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Receives Provisional Cultivation License
VANCOUVER, British Columbia, Oct. 3, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has received a Provisional Nursery License for Core Isogenics Inc.
Oct 03, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., Receives Provisional Cultivation License
VANCOUVER, British Columbia, Oct. 3, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces it has received a Provisional Nursery License for Core Isogenics Inc.
Oct 01, 2019 08:00 am ET
Core One Labs Inc. Completes Construction of Water Main to Dispensary Property
VANCOUVER, British Columbia, Oct. 1, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("Core One" or the "Company") announces that its wholly-owned subsidiary, LDS Development Corporation, has completed the construction of connecting into the City of Adelanto's water system and routing it to the property along with the completion of installation of a fire hydrant, as required by the San Bernardino county fire department. 
Oct 01, 2019 08:00 am ET
Core One Labs Inc. Completes Construction of Water Main to Dispensary Property
VANCOUVER, British Columbia, Oct. 1, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("Core One" or the "Company") announces that its wholly-owned subsidiary, LDS Development Corporation, has completed the construction of connecting into the City of Adelanto's water system and routing it to the property along with the completion of installation of a fire hydrant, as required by the San Bernardino county fire department. 
Sep 27, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., has been Granted Annual Nursery License
VANCOUVER, British Columbia, Sept. 27, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its wholly-owned subsidiary, Core Isogenics Inc., has been awarded a Provisional Nursery License.
Sep 27, 2019 08:00 am ET
Core One Labs' Subsidiary, Core Isogenics Inc., has been Granted Annual Nursery License
VANCOUVER, British Columbia, Sept. 27, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces its wholly-owned subsidiary, Core Isogenics Inc., has been awarded a Provisional Nursery License.
Sep 16, 2019 08:00 am ET
Core One Labs Grants Options to Officers, Directors, and Consultants
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2019) - Core One Labs Inc. (CSE: COOL) (OTCQX: LDSYD) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announces that the Company has granted options to purchase up to 1,847,600 common shares to its executive officers, directors, and consultants. The options granted may be exercised at a price of $1.25 per share and expire on September 1, 2021. Options to acquire up to 1,383,000 common shares vested immediately, and options to acquire up to 464,600 common shares issued to a consultant for investor relations services vest over a 12-month period beginning on December 13, 2019 at 116,150 shares per quarter.
Sep 12, 2019 08:00 am ET
Core One Labs Inc. Announces Subsidiary Agrotech LLC. Concludes its First Harvest of Sacramento Farm
VANCOUVER, British Columbia, Sept. 12, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its subsidiary, Agrotech LLC, has concluded its first harvest of 1,600 pounds from its Sacramento farm and has begun processing the bio-mass.
Sep 12, 2019 08:00 am ET
Core One Labs Inc. Announces Subsidiary Agrotech LLC. Concludes its First Harvest of Sacramento Farm
VANCOUVER, British Columbia, Sept. 12, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its subsidiary, Agrotech LLC, has concluded its first harvest of 1,600 pounds from its Sacramento farm and has begun processing the bio-mass.
Sep 09, 2019 08:00 am ET
Core One Labs Inc. Announces Start of Construction on the Highway 395 Dispensary Project
VANCOUVER, British Columbia, Sept. 9, 2019 /CNW/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, LDS Development Corporation, has received grading permits and broke ground on the Highway 395 Dispensary project. The Adelanto Mayor, Gabriel Reyes, City Manager, Jessie Flores, and members of the City Council were all in attendance with shovels for the ground breaking.
Sep 09, 2019 08:00 am ET
Core One Labs Inc. Announces Start of Construction on the Highway 395 Dispensary Project
VANCOUVER, British Columbia, Sept. 9, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: LDSYD), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that its wholly-owned subsidiary, LDS Development Corporation, has received grading permits and broke ground on the Highway 395 Dispensary project. The Adelanto Mayor, Gabriel Reyes, City Manager, Jessie Flores, and members of the City Council were all in attendance with shovels for the ground breaking.